N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
about
Contractions induced by potassium-free solution and potassium relaxation in vascular smooth muscle of hypertensive and normotensive ratsRegulation of cellular communication by signaling microdomains in the blood vessel wall.NG-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized ratIn vivo assessment of microvascular nitric oxide production and its relation with blood flow.Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor.Peritubular fluid viscosity modulates H+ flux in proximal tubules through NO release.Endogenous nitric oxide and sensory neuropeptides interact in the modulation of the rat gastric microcirculation.The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the ratChronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs.Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.Nitrergic transmission: nitric oxide as a mediator of non-adrenergic, non-cholinergic neuro-effector transmission.Platelet-derived growth factor receptors on macrovascular endothelial cells mediate relaxation via nitric oxide in rat aorta.Intravascular filarial parasites inhibit platelet aggregation. Role of parasite-derived prostanoids.NMDA and nitric oxide act through the cGMP signal transduction pathway to repress hypothalamic gonadotropin-releasing hormone gene expressionInfluence of NG-nitro-L-arginine on non-adrenergic non-cholinergic relaxation in the guinea-pig gastric fundus.Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta.The role of nitric oxide in inhibitory non-adrenergic non-cholinergic neurotransmission in the canine lower oesophageal sphincter.Regional coronary haemodynamic effects of two inhibitors of nitric oxide synthesis in anaesthetized, open-chest dogs.Endothelial modulation of vasoconstrictor responses to endothelin-1 in human placental stem villi small arteriesEndothelium-dependent relaxation and hyperpolarization evoked by bradykinin in canine coronary arteries: enhancement by exercise-training.Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated tracheaEvidence for nitric oxide as mediator of non-adrenergic non-cholinergic relaxations induced by ATP and GABA in the canine gutRoles of prostacyclin, EDRF and active oxygens in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitroEndogenous nitric oxide: physiology, pathology and clinical relevance.Overproduction of nitric oxide inhibits vascular reactivity in portal hypertensive rats.Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cellsHypothyroidism and hypertension.Nitric oxide-based possibilities for pharmacotherapy.Endothelium-dependent tolerance to ethanol-induced contraction of rat aorta: effect of inhibition of EDRF action and nitric oxide synthesis.Attenuation of pressure-induced myogenic contraction and tyrosine phosphorylation by fasudil, a cerebral vasodilator, in rat cerebral artery.Bacterial endotoxin rapidly stimulates prolonged endothelium-dependent vasodilatation in the rat isolated perfused heart.Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine.Effect of carbenoxolone on the biological activity of nitric oxide: relation to gastroprotection.L-NG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse.Involvement of platelet cyclic GMP but not cyclic AMP suppression in leukocyte-dependent platelet adhesion to endothelial cells induced by platelet-activating factor in vitroPost-receptor pathway of the ATP-induced relaxation in smooth muscle of the mouse vas deferens.Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.PGF2 alpha causes bronchoconstriction and pulmonary vasoconstriction via thromboxane receptors in rat lung.Haemodynamic responses to NG-monomethyl-L-arginine in spontaneously hypertensive and normotensive Wistar-Kyoto rats.Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats
P2860
Q28396169-E1A28BD6-1F71-4F7E-858A-D1E63494719CQ30406156-4B3C244D-220F-4BCB-BD38-C03E043EC46EQ30498821-14701BDB-872A-45DC-970E-F603F581CC41Q31940541-00555804-20C1-4E28-A1C4-40B5E28FF6A6Q32019835-2103E941-B1AD-4BB6-9D9B-D7377327218DQ32032102-493C3481-A9A1-4229-AAA8-82041A1AC1CBQ33217464-B615A930-E68E-4775-A9AB-9266B11AFB90Q33343457-C4DA6FD8-001C-48FD-BAC0-9A1D01CB20BFQ34153369-3236EC3D-41A4-4D41-8807-4495AD48706BQ34188127-3B064227-2D62-4F6F-8318-5D0306054B94Q35232873-6777E4C4-DFAB-4201-ACDC-2A2BAC2C5E54Q35599183-DCCB0785-DC8D-4163-A208-CD581292006CQ35600205-60D2B75E-9E35-4466-AB2B-D3B7C87A351BQ35844187-4866DB9E-4F93-4614-9EFB-4D87C5F8C906Q35870552-F962967B-333D-49C4-B667-3A97887F5EB8Q35871096-CB20AB6D-3960-4F71-8763-709701400041Q35871613-2AEE0E23-73CE-4B42-9F57-19C5272C772FQ35871827-D4E29754-7636-4CC7-8003-EE03E337EED2Q35872899-D5B71E86-3FEC-4B05-A9E0-8C8CFBC2C359Q35873294-A9A35905-5683-449C-AFCB-96840633534FQ35874290-FFCE302D-9E44-4B31-AFB2-CC85227F372FQ35888790-4612773E-56C1-45B1-B841-3DE327A79664Q36329615-4184603A-E4BF-4DC9-9E8D-0F7DE1048A1CQ36691847-5163657C-4AD6-4429-B995-AD06156197E8Q36724510-DCAFF8B3-E8D3-4772-9812-2641A84FFEB4Q37628594-B8C89015-CCB0-41E9-8619-99A4AE9B5B16Q37810908-9C2402B7-0C30-4891-A52D-CA8E18A5D798Q40405202-B39B188C-B6F9-47EB-9A4F-ADF3A5B28DF3Q41115146-34EF4E9B-1EDC-4A68-B507-35757623A8CCQ41784902-4E750147-6C3B-49E4-879B-68FA81A5BA22Q41817467-4F53B2D8-8A1D-48E9-8A80-3BFCD8A31562Q41950416-5A6E13B2-2717-4CD3-A328-067F2E4E26A5Q42009094-08BB477B-B5A1-4A3A-B297-50ADF733F916Q42032052-AC728082-449E-4F4D-8BE1-050E0F1A057DQ42151089-E083E27F-2A1F-4A15-AE95-948D97E9EA8EQ42254069-EBFC238A-EF66-4BE9-B482-BDA24B28C8A1Q42369018-FE621650-B702-482C-8C59-B6912CB6C611Q42431622-75C71584-00BC-4777-BA10-ECE7C73DEB03Q42560758-26064845-6A8C-4179-9B92-B6B4E12AF03CQ42561790-F12828F8-6DF1-48AA-88D2-727EADDF53D3
P2860
N omega-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@en
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@nl
type
label
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@en
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@nl
prefLabel
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@en
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@nl
P2093
P1476
N omega-nitro-L-arginine: a po ...... ved relaxing factor formation.
@en
P2093
P304
P356
10.1016/0014-2999(90)90531-A
P407
P577
1990-02-01T00:00:00Z